AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the company.Most analysts estimate the trial miss wiped...
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in Mumbai, India, June 24,...